Valuation : Augmedix, Inc.

Market Cap 116M 99.95M 94.04M 85.91M 161M 10.97B 161M 1.11B 431M 5.63B 436M 427M 18.13B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 82.42M 77.55M 70.84M 133M 9.04B 133M 916M 356M 4.64B 360M 352M 14.95B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 02/10/2024
Director of Finance/CFO - 02/10/2024
Chief Operating Officer - 02/10/2024
Director TitleAgeSince
Director/Board Member 63 10/04/2023
Director/Board Member - 02/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/24 Issuer sale

Chief Financial Officer

754,058 1.5256%
02/10/24 Issuer sale

Director

74,230 0.1502%
02/10/24 Issuer sale

Director

93,047 0.1882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-53.19% 116M
-0.29%-1.82%-3.08%+58.71% 80.22B
-0.89%-3.78%+1.73%+8.01% 17.11B
-0.18%-0.69%+4.29%+9.90% 14.04B
+0.26%+0.26%+26.57%+40.29% 12.16B
-1.08%-1.26%+18.59%+84.84% 8.03B
+0.07%-3.44%+50.94%+129.62% 6.83B
-2.00%-1.84%-17.01%-1.35% 6.27B
-1.85%-4.61%-17.00%+25.02% 5.55B
-0.60%+0.76%+13.92%-0.82% 5.33B
Average -0.66%-0.90%+7.90%+30.10% 15.57B
Weighted average by Cap. -0.46%-1.42%+3.44%+46.01%

Financials

2022 2023
Net sales 30.93M 26.62M 25.04M 22.88M 42.8M 2.92B 42.91M 296M 115M 1.5B 116M 114M 4.83B 44.86M 38.6M 36.32M 33.17M 62.06M 4.24B 62.23M 429M 167M 2.17B 168M 165M 7B
Net income -24.45M -21.04M -19.79M -18.08M -33.83M -2.31B -33.92M -234M -90.76M -1.18B -91.81M -89.81M -3.82B -19.17M -16.5M -15.52M -14.18M -26.52M -1.81B -26.6M -183M -71.17M -929M -71.99M -70.42M -2.99B
Net Debt -4.28M -3.68M -3.46M -3.16M -5.92M -404M -5.93M -40.92M -15.88M -207M -16.06M -15.71M -667M -20.37M -17.53M -16.49M -15.07M -28.18M -1.92B -28.26M -195M -75.63M -987M -76.5M -74.83M -3.18B
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock